🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 196 of 200 · A–Z by INN

  1. vitamin a

    VITAMIN A

    ORAL FDA: approved

  2. vitamin a palmitate

    VITAMIN A PALMITATE Teva Pharma GmbH

    INJECTION FDA: approved

  3. vitamins, minerals and trace elements

    PHLEXY-VITS

    TGA: approved

  4. vitamins, minerals and trace elements with carbohydrate

    FRUITIVITS Talion

    TGA: approved

  5. voclosporin

    LUVENIQ Aurinia Pharmaceuticals

    ORAL FDA: approved · EMA: approved · PMDA: approved

    L04AD03

  6. volanesorsen

    WAYLIVRA

    EMA: approved

    C10AX18

  7. vonicog alfa

    VEYVONDI

    EMA: approved

    B02BD10

  8. vonoprazan fumarate

    TAKECAB Phathom Pharmaceuticals

    ORAL FDA: approved · PMDA: approved

  9. vorapaxar

    ZONTIVITY

    EMA: withdrawn

    B01

  10. vorapaxar sulfate

    ZONTIVITY

    ORAL FDA: approved

  11. vorasidenib

    VORANIGO

    ORAL FDA: approved · EMA: approved

    L01XM04

  12. voretigene neparvovec

    LUXTURNA

    EMA: approved

    S01XA27

  13. voriconazole

    VFEND Pfizer Australia Pty Ltd

    IV (INFUSION) FDA: approved · EMA: approved · TGA: approved

    J02AC03

  14. vorinostat

    ZOLINZA Merck KGaA, Darmstadt, Germany

    ORAL FDA: approved · EMA: application withdrawn · TGA: approved

  15. vortioxetine

    BRINTELLIX

    ORAL FDA: approved · EMA: approved

    N06AX26

  16. vortioxetine hydrobromide

    VORTIOXETINE HYDROBROMIDE Takeda

    ORAL FDA: approved

  17. vosaroxin

    QINPREZO

    EMA: application withdrawn

    L01

  18. vosoritide

    VOXZOGO BioMarin Pharmaceutical Australia Pty Ltd

    SUBCUTANEOUS FDA: approved · EMA: approved · TGA: approved

    M05BX

  19. votumumab

    HUMASPECT

    EMA: withdrawn

    V09IX

  20. voxelotor

    OXBRYTA

    ORAL FDA: approved · EMA: suspended

    B06AX03

  21. vrt106

    NMPA: clinical trials

  22. vsa006

    NMPA: clinical trials

  23. vutrisiran

    AMVUTTRA Lacuna Pharma Pty Ltd

    EMA: approved · TGA: approved

    N07XX18

  24. vutrisiran sodium

    AMVUTTRA Alnylam Netherlands B.V.

    SUBCUTANEOUS FDA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources